NNOX

NANO-X IMAGING LTD

Regulated industry Physical products Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Advanced Metrics

NNOX Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$8.58M	$9.90M	$11.28M	$13.02M
Cost of Revenue	$15.46M	$16.50M	$21.89M	$25.81M
Gross Profit	-$6.88M	-$6.59M	-$10.61M	-$12.79M
Research & Development	$26.51M	$26.05M	$20.18M	$19.24M
Selling, General & Admin	$45.63M	$28.44M	$25.75M	$27.10M
Operating Expenses	$80.33M	$53.06M	$46.14M	$47.91M
Operating Income	-$87.21M	-$59.66M	-$56.75M	-$60.70M
EBITDA	-$75.70M	-$47.85M	-$45.01M	-$49.00M
Pretax Income	-$116.92M	-$61.12M	-$53.87M	-$76.81M
Income Tax	-$3.68M	-$339.00K	-$358.00K	-$1.79M
Net Income	-$113.24M	-$60.78M	-$53.52M	-$75.02M
Diluted EPS	-2.01	-1.08	-0.91	-1.16
Diluted Shares	52.23M	56.37M	58.67M	64.79M

NNOX Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$38.46M	$56.38M	$39.30M	$49.15M
Receivables	$977.00K	$1.48M	$1.80M	$2.01M
Inventory	$0.00	$2.36M	$1.49M	$3.07M
Current Assets	$82.46M	$88.64M	$78.68M	$66.79M
Total Assets	$253.93M	$218.65M	$210.00M	$162.16M
Current Liabilities	$25.07M	$15.52M	$13.97M	$16.89M
Long-Term Debt	$3.48M	—	—	—
Total Debt	$4.62M	$8.40M	$7.45M	$7.85M
Total Liabilities	$37.25M	$23.13M	$20.88M	$22.43M
Retained Earnings	-$259.46M	-$320.23M	-$373.75M	-$448.77M
Shareholders' Equity	$216.68M	$195.51M	$189.12M	$139.73M
Working Capital	$57.39M	$73.11M	$64.71M	$49.91M

NNOX Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$43.38M	-$44.78M	-$36.60M	-$40.79M
Capital Expenditure	-$7.17M	-$3.30M	-$2.77M	-$4.21M
Free Cash Flow	-$50.56M	-$48.08M	-$39.37M	-$45.00M
Depreciation & Amortisation	$11.51M	$11.81M	$11.73M	$11.70M
Stock-Based Compensation	$18.62M	$6.84M	$7.26M	$4.19M
Investing Cash Flow	$14.61M	$35.43M	-$20.05M	$29.37M
Financing Cash Flow	$804.00K	$27.25M	$39.50M	$21.37M
Net Change in Cash	-$27.98M	$17.91M	-$17.14M	$9.95M

NNOX Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$2.81M	$3.04M	$3.45M	$3.72M	$4.31M	$4.16M
Cost of Revenue	$5.86M	$6.28M	$6.33M	$7.34M	$6.90M	$47.83M
Gross Profit	-$3.05M	-$3.24M	-$2.88M	-$3.62M	-$2.59M	-$43.67M
Research & Development	$4.98M	$4.83M	$4.59M	$4.84M	$4.80M	$4.71M
Selling, General & Admin	$6.08M	$6.37M	$6.76M	$7.89M	$7.40M	$7.34M
Operating Expenses	$11.04M	$11.25M	$11.35M	$14.27M	$11.94M	$11.80M
Operating Income	-$14.09M	-$14.49M	-$14.23M	-$17.88M	-$14.53M	-$55.48M
EBITDA	-$11.15M	-$11.54M	-$11.28M	-$15.04M	-$11.71M	-$52.66M
Pretax Income	-$13.32M	-$14.64M	-$13.78M	-$35.07M	-$14.19M	-$55.54M
Income Tax	-$86.00K	$82.00K	-$94.00K	-$1.69M	$76.00K	-$51.00K
Net Income	-$13.24M	-$14.72M	-$13.68M	-$33.37M	-$14.27M	-$55.49M
Diluted EPS	-0.21	-0.23	-0.21	-0.50	-0.20	-0.79
Diluted Shares	63.95M	63.91M	64.32M	67.06M	69.62M	69.93M

NNOX Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$40.37M	$49.90M	$45.19M	$49.15M	$43.85M	$31.02M
Receivables	$1.72M	$1.88M	$1.94M	$2.01M	$2.21M	$1.89M
Inventory	$1.75M	$2.25M	$2.67M	$3.07M	$3.27M	$3.42M
Current Assets	$67.97M	$57.48M	$51.31M	$66.79M	$51.33M	$38.99M
Total Assets	$196.74M	$184.23M	$176.09M	$162.16M	$145.77M	$91.19M
Current Liabilities	$12.83M	$13.71M	$12.39M	$16.89M	$14.12M	$13.71M
Total Debt	$7.40M	$7.95M	$7.88M	$7.85M	$7.64M	$7.73M
Total Liabilities	$19.57M	$20.67M	$19.38M	$22.43M	$19.46M	$18.72M
Retained Earnings	-$386.99M	-$401.71M	-$415.39M	-$448.77M	-$463.03M	-$518.52M
Shareholders' Equity	$177.16M	$163.56M	$156.71M	$139.73M	$126.31M	$72.47M
Working Capital	$55.14M	$43.77M	$38.92M	$49.91M	$37.21M	$25.27M

NNOX Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	-$10.33M	-$9.31M	-$10.74M	-$10.41M	-$13.95M	-$11.59M
Capital Expenditure	-$527.00K	-$1.05M	-$1.74M	-$888.00K	-$1.78M	-$984.00K
Free Cash Flow	-$10.85M	-$10.36M	-$12.48M	-$11.30M	-$15.73M	-$12.58M
Depreciation & Amortisation	$2.94M	$2.95M	$2.96M	$2.85M	$2.82M	$2.82M
Stock-Based Compensation	$1.17M	$1.11M	$1.10M	$814.00K	$841.00K	$869.00K
Investing Cash Flow	$11.27M	$18.95M	$260.00K	-$1.10M	$8.68M	-$892.00K
Financing Cash Flow	$121.00K	$0.00	$5.74M	$15.51M	$0.00	-$127.00K
Net Change in Cash	$1.06M	$9.64M	-$4.74M	$3.99M	-$5.27M	-$12.61M

NANO-X IMAGING LTD is an Israeli medical imaging company developing digital X-ray technology to make medical imaging more accessible and affordable.